Assembly Biosciences, Inc. ( ASMB) - Stock Earnings
ASMB Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -9.2 million USD | 10.8 million USD |
| 2025Q4 | 22.1 million USD | 42.5 million USD |
| 2026Q1 | -9.1 million USD | 8.2 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ASMB Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -61.2 million USD | 7.2 million USD |
| 2024 | -40.2 million USD | 28.5 million USD |
| 2025 | -6.1 million USD | 72.3 million USD |
| 2026 Est. | — | — |
ASMB
Price: $23.33
52 week price:
Earnings Per Share: 0.08 USD
P/E Ratio: 380.13
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 311844
Ebitda: -12.4 millionMarket Capitalization: 385.4 million